. Therebewteen cytochrome c, Apaf-1, and Apaf-3. BCL-2-like proteins fore, in C. elegans it appears that CED-4 is an adaptor inhibit caspase activation by either binding directly to the adaptor protein that can receive an apoptotic signal, bind to proprotein (Apaf-1 or CED-4), preventing release of cytochrome c, or both.
CED-3, and cause it to release its activated proteolytic
The genetics of cell death in C. elegans and biochemiin physiological circumstances, or does another nucleotide play this role? What is the role of nucleotide bindcal evidence of a direct interaction between CED-9 and ing-does it act as a switch to change the conformation CED-4 suggest that, before we can really understand and activity of Apaf-1, as occurs in G proteins, or is ATP how BCL-2-like proteins function, we will need to find used as energy to drive a reaction? What protein is the mammalian homolog(s) of CED-4. This search now responsible for cleaving the caspase precursor-is it appears to be over.
autocatalytic, or can one of the Apafs act as a protease?
A Human Protein Resembling CED-4
What is the identity of Apaf-3-will it turn out to resemble Using a biochemical approach to analyze cytosolic proknown proteins, such as one of the proapoptotic BCL-2 teins that can activate caspase-3, Xiaodong Wang and family members, or will it be completely novel? What is coworkers have isolated a number of Apoptosis activatthe relationship, if any, between Apafs 1-3 and apoing factors (Apafs 1-3) (Zou et al., 1997) . Addition of ptosis-inducing factor (AIF), a 50 kDa caspase activatdATP to these purified proteins results in cleavage and ing protein released from the mitochondria (Kroemer, activation of the caspase-3 precursor. Earlier work re-1997)? Do human BCL-2-like proteins bind to human vealed Apaf-2 to be cytochrome c, which was released CED-4-like proteins? Apoptosis remains one of the hotfrom the mitochondria during homogenization. Apaf-3 test areas of biological research. Chances are we won't is a 45 kDa protein that has not yet been cloned. Apaf-1 have to wait long to find out. was found to resemble CED-4. It has an amino-terminal CARD domain and a 320 amino acid central portion with and Apaf-3 are sufficient to activate pro-caspase-3, Seshagiri, S., and Miller, L.K. (1997) . Curr. Biol. 7, [455] [456] [457] [458] [459] [460] demonstrating that, in addition to CED-3 and CED-9, Spector, M.S., Desnoyers, S., Hoeppner, D.J., and Hengartner, M.O.
the CED-4 component of the apoptotic mechanism is (1997) . Nature 385, [653] [654] [655] [656] highly conserved. Cytochrome c was found to associate Strasser, A., Harris, A.W., Huang, D., Krammer, P.H., and Cory, S.
with Apaf-1 in the presence or absence of dATP. (1995) . EMBO J. 14, 6136-6147. Vaux, D.L., Weissman, I.L., and Kim, S.K. (1992) . Science 258, 1955- A model for caspase activation is shown in Figure 1. 
Remaining Riddles

1957.
We still do not know precisely how BCL-2/CED-9-like Wu, D.Y., Wallen, H.D., and Nunez, G. (1997) . Science 275, 1126- proteins work. If they prevent apoptosis by blocking 1129. cytochrome c release, why would they need to bind to It may be that BCL-2 proteins perform both functions. Another possibility is that BCL-2 may retain cytochrome c in the mitochondria indirectly. If cytochrome c was only one of a number of factors that can cause CED-4 to activate the caspases, induction of apoptosis by these alternate pathways might lead to a secondary loss of mitochondrial function, release of cytochrome c, and an amplification of the apoptotic cascade. In such a scenario, BCL-2-like proteins would only act as CED-4 inhibitors, with their ability to prevent cytochrome c release being indirect, by inhibiting the initial, premitochondrial caspase activation.
Clearly, the experiments of Wang and coworkers have answered some questions but, like much good research, generated still more: Is dATP a regulator of apoptosis
